IzotropicFRA:1R3 +20.90%28 Days Payable is 0.00 as of Jan. 2026. GuruFocus rates FRA:1R3 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 191 Medical Diagnostics & Research companies, Izotropic ranks worse than 523559.69% on this metric.
The historical rank and industry rank for Izotropic's Days Payable or its related term are showing as below:
FRA:1R3's Days Payable is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 65.09 * Ranked among companies with meaningful Days Payable only.
Izotropic's Days Payable
stayed the same
from Jan. 2025 (0.00) to Jan. 2026 (0.00).
stayed the same
Izotropic Days Payable Related Terms
Izotropic Days Payable Historical Data
* Premium members only.
The historical data trend for Izotropic's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1R3 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Izotropic's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Izotropic Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Izotropic's Days Payable distribution charts can be found below:
* The bar in red indicates where Izotropic's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Izotropic's Days Payable for the fiscal year that ended in Apr. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Izotropic (FRA:1R3) has a Days Payable of 0.00 as of Jan. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Izotropic and its competitors. According to the industry distribution chart, Izotropic ranks #999999 out of 191 companies in the Medical Diagnostics & Research industry.
Is Izotropic's Days Payable too high?
Izotropic's current Days Payable is 0.00. Based on the distribution chart, Izotropic ranks #999999 out of 191 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Izotropic has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Izotropic's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Izotropic ranks #999999 out of 191 companies for Days Payable. This places Izotropic in the lower half of its industry. The industry median Days Payable is 65.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 65.09, based on 191 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Izotropic and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 65.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Izotropic's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Izotropic stock overvalued right now?
Izotropic (FRA:1R3) has a current Days Payable of 0.00. The current Days Payable is 0.00. Izotropic's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Izotropic (FRA:1R3), the current Days Payable is 0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Izotropic Corp is a research and development company specializing in cancer research and early detection for breast cancer. It is engaged in advancing breast cancer imaging through the commercialization of medical imaging technologies. The company's current focus is on the commercialization of its first medical imaging device, IzoView, a dedicated Breast CT Imaging System, developed to provide high resolution, true 3D volumetric visualization of the breast without compression for breast cancer detection and diagnosis.
28GF Score
Get the complete analysis for FRA:1R3
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1R3 has been successfully added to your 
